Decoding intracellular signaling in atrial fibrillation — From the magic lens of Western blot to clinical practice
References
- Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, De Potter TJR, Dwight J, Guasti L, Hanke T, Jaarsma T, Lettino M, Løchen ML, Lumbers RT, Maesen B, Mølgaard I, Rosano GMC, Sanders P, Schnabel RB, Suwalski P, Svennberg E, Tamargo J, Tica O, Traykov V, Tzeis S, Kotecha D; ESC Scientific Document Group. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45:3314–414.
- Balan AI, Pintilie I, Somkereki C, Perian M, Chinezu L, Banescu C, Serban RC, Scridon A. Role of Preexisting Proarrhythmic Atrial Remodeling in Post-Coronary Artery Bypass Grafting Atrial Fibrillation. Romanian Journal of Cardiology. 2021;31:597.
- Balan AI, Halaţiu VB, Scridon A. Oxidative Stress, Inflammation, and Mitochondrial Dysfunction: A Link between Obesity and Atrial Fibrillation. Antioxidants. 2024;13:117.
- Chen PS, Chen LS, Fishbein MC, Lin SF, Nattel S. Role of the Autonomic Nervous System in Atrial Fibrillation: Pathophysiology and Therapy. Circ Res. 2014;114:1500–15.
- Nattel S, Heijman J, Zhou L, Dobrev D. Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy. Circulation Research. 2020;127:51–72.
- Mahmood T, Yang PC. Western Blot: Technique, Theory, and Trouble Shooting. N Am J Med Sci. 2012;4:429–34.
- Loehr JA, Latchman HK, Murphy RM, Cully TR. Extraction of Total Protein from Cardiomyocytes and Western Blotting Analysis. Methods Mol Biol. 2025;2894:151–61.
- Peukert S, Gulgeze Efthymiou HB, Mo R, Peng Y, Ma F, Barbe G, Bebernitz G, Fridrich C, Buono C, Williams ET, Daniels T, Li L, Zhang X, Adachi Y, Abe M, Taggart AKP. Discovery of a brain-sparing GIRK1/4 inhibitor for pharmacological cardioversion of atrial fibrillation. Bioorg Med Chem Lett. 2023;85:129237.
- Molina CE, Abu-Taha IH, Wang Q, Roselló-Díez E, Kamler M, Nattel S, Ravens U, Wehrens XHT, Hove-Madsen L, Heijman J, Dobrev D. Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial Fibrillation. Front Physiol. 2018;9: 1383.
- Campbell HM, Quick AP, Abu-Taha I, Chiang DY, Kramm CF, Word TA, Brandenburg S, Hulsurkar M, Alsina KM, Liu HB, Martin B, Uhlenkamp D, Moore OM, Lahiri SK, Corradini E, Kamler M, Heck AJR, Lehnart SE, Dobrev D, Wehrens XHT. Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation. Circulation. 2020;142: 1159–72.
- Meng T, Cheng G, Wei Y, Ma S, Jiang Y, Wu J, Zhou X, Sun C. Exposure to a chronic high-fat diet promotes atrial structure and gap junction remodeling in rats. Int J Mol Med. 2017;40:217–25.
- Chiang DY, Li N, Wang Q, Alsina KM, Quick AP, Reynolds JO, Wang G, Skapura D, Voigt N, Dobrev D, Wehrens XH. Impaired local regulation of ryanodine receptor type 2 by protein phosphatase 1 promotes atrial fibrillation. Cardiovasc Res 2014;103: 178–87.
- Lugenbiel P, Wenz F, Govorov K, Syren P, Katus HA, Thomas D. Atrial myofibroblast activation and connective tissue formation in a porcine model of atrial fibrillation and reduced left ventricular function. Life Sci. 2017;181:1–8.
- Mayama T, Matsumura K, Lin H, Ogawa K, Imanaga I. Remodelling of cardiac gap junction connexin 43 and arrhythmogenesis. Exp Clin Cardiol. 2007;12: 67–76.
- Rostas JAP, Skelding KA. Calcium/Calmodulin-Stimulated Protein Kinase II (CaMKII): Different Functional Outcomes from Activation, Depending on the Cellular Microenvironment. Cells. 2023;12:401.
- Heijman J, Voigt N, Wehrens XHT, Dobrev D. Calcium dysregulation in atrial fibrillation: the role of CaMKII. Front Pharmacol. 2014;5:30.
- Liu Z, Finet JE, Wolfram JA, Anderson ME, Ai X, Donahue JK. Calcium/calmodulin-dependent protein kinase II causes atrial structural remodeling associated with atrial fibrillation and heart failure. Heart Rhythm. 2019;16:1080–8.
- Wakili R, Yeh YH, Yan Qi X, Greiser M, Chartier D, Nishida K, Maguy A, Villeneuve LR, Boknik P, Voigt N, Krysiak J, Kääb S, Ravens U, Linke WA, Stienen GJ, Shi Y, Tardif JC, Schotten U, Dobrev D, Nattel S. Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ Arrhythm Electrophysiol. 2010;3:530–41.
- Tessier S, Karczewski P, Krause EG, Pansard Y, Acar C, Lang-Lazdunski M, Mercadier JJ, Hatem SN. Regulation of the transient outward K(+) current by Ca(2+)/calmodulin-dependent protein kinases II in human atrial myocytes. Circ Res. 1999;85:810–9.
- Voigt N, Li N, Wang Q, Wang W, Trafford AW, Abu-Taha I, Sun Q, Wieland T, Ravens U, Nattel S, Wehrens XH, Dobrev D. Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation. 2012;125:2059–70.
- Mangmool S, Shukla AK, Rockman HA. beta-Arrestin-dependent activation of Ca(2+)/calmodulin kinase II after beta(1)-adrenergic receptor stimulation. J Cell Biol. 2010;189:573–87.
- Grimm M, Brown JH. Beta-adrenergic receptor signaling in the heart: role of CaMKII. J Mol Cell Cardiol. 2010;48:322–30.
- Purohit A, Rokita AG, Guan X, Chen B, Koval OM, Voigt N, Neef S, Sowa T, Gao Z, Luczak ED, Stefansdottir H, Behunin AC, Li N, El-Accaoui RN, Yang B, Swaminathan PD, Weiss RM, Wehrens XH, Song LS, Dobrev D, Maier LS, Anderson ME. Oxidized Ca(2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation. Circulation. 2013;128:1748–57.
- Morrison DK. MAP Kinase Pathways. Cold Spring Harb Perspect Biol 2012;4(11):a011254.
- Ai X, Yan J, Carrillo E, Ding W. The Stress-Response MAP Kinase Signaling in Cardiac Arrhythmias. Rev Physiol Biochem Pharmacol. 2016;172:77–100.
- Yan J, Kong W, Zhang Q, Beyer EC, Walcott G, Fast VG, Ai X. c-Jun N-terminal kinase activation contributes to reduced connexin43 and development of atrial arrhythmias. Cardiovasc Res. 2013;97:589–97.
- Yan J, Bare DJ, DeSantiago J, Zhao W, Mei Y, Chen Z, Ginsburg K, Solaro RJ, Wolska BM, Bers DM, Chen SRW, Ai X. JNK2, a Newly Identified SERCA2 Enhancer, Augments an Arrhythmic [Ca2+]SR Leak-Load Relationship. Circ Res. 2021;128:455–70.
- Zhang D, Chen X, Wang Q, Wu S, Zheng Y, Liu X. Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in postoperative atrial fibrillation. PLOS ONE. 2017;12:e0173759.
- Goette A, Staack T, Röcken C, Arndt M, Geller JC, Huth C, Ansorge S, Klein HU, Lendeckel U. Increased expression of extracellular signal regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. JACC. 2000;35:1669–77.
- Wang Z, Ren Y, Zhang D, She G, Wang Y, Li G, Sun X, Zheng D, Wang Z, Deng XL, Zhao Y, Zhao L. Elevated KCa3.1 expression by angiotensin II via the ERK/NF-κB pathway contributes to atrial fibrosis. J Mol Cell Cardiol. 2025;202:133–43.
- Kaikkonen L, Magga J, Ronkainen VP, Koivisto E, Perjes Á, Chuprun JK, Vinge LE, Kilpiö T, Aro J, Ulvila J, Alakoski T, Bibb JA, Szokodi I, Koch WJ, Ruskoaho H, Kerkelä R. p38α regulates SERCA2a function. J Mol Cell Cardiol. 2014;67:86–93.
- Zheng J, Zhao S, Yang Q, Wei Y, Li J, Guo T. Sympathetic Activation Promotes Cardiomyocyte Apoptosis in a Rabbit Susceptibility Model of Hyperthyroidism-Induced Atrial Fibrillation via the p38 MAPK Signaling Pathway. Crit Rev Eukaryot Gene Expr. 2023;33:17–27.
- Nishida K, Yamaguchi O, Hirotani S, Hikoso S, Higuchi Y, Watanabe T, Takeda T, Osuka S, Morita T, Kondoh G, Uno Y, Kashiwase K, Taniike M, Nakai A, Matsumura Y, Miyazaki J, Sudo T, Hongo K, Kusakari Y, Kurihara S, Chien KR, Takeda J, Hori M, Otsu K. p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol Cell Biol. 2004;24: 10611–20.
- Xu W, Yu CY, Wang DY, Gao Q, Zhang S, Zhang Y, Yuan Y, Shi J, Li Y, Liu GZ, Shang XM. Eplerenone Inhibits Atrial Autonomic Nerve Remodeling in Atrial Fibrillation Through ERK1/2 MAPK Pathway. Cardiovasc Ther. 2025;2025:6041636.
- Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z, Nattel S. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001;104:2608–14.
- Heijman J, Voigt N, Wehrens XH, Dobrev D. Calcium dysregulation in atrial fibrillation: the role of CaMKII. Front Pharmacol. 2014;5:30.
- Shantsila E, Shahid F, Sun Y, Deeks J, Calvert M, Fisher JP, Kirchhof P, Gill PS, Lip GYH. Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS-AF Trial. J Am Heart Assoc. 2020;9:e016239.
- Nattel S, Heijman J, Zhou L, Dobrev D. Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective. Circ Res. 2020;127(1):51–72.
- Hadi HA, Carr CS, Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag. 2005;1:183–98.
- Liu T, Gong M, Yang Y, Li H, Liang X, Zhang Z, Yuan M, Zhang Y, Jiao Z, Tse G, Li G. Rapamycin attenuates atrial fibrosis in 5/6 nephrectomized rats by inhibiting mTOR and pro-fibrotic signaling, European Heart Journal. 2017;38:ehx502.
- Flynn JM, O’Leary MN, Zambataro CA, Academia EC, Presley MP, Garrett BJ, Zykovich A, Mooney SD, Strong R, Rosen CJ, Kapahi P, Nelson MD, Kennedy BK, Melov S. Late-life rapamycin treatment reverses age related heart dysfunction. Aging Cell. 2013;12:851–62.
- Gao G, Dudley SC Jr. Redox regulation, NF-kappaB, and atrial fibrillation. Antioxid Redox Signal. 2009;11:2265–77.
- Zhang YL, Xu ZY, Sun Y, Zhu QQ, Tang SX, Zhong QH, Han X. 4-Hydroxychalcone alleviated Angiotensin II-induced atrial fibrillation via immunoproteasome-IKK-NF-κB signaling pathway modulation. J Mol Med. 2025;103:1405–1416.
- Zhao Y, Gu TX, Zhang GW, Liu HG, Wang C. Losartan affects the substrate for atrial fibrillation maintenance in a rabbit model. Cardiovasc Pathol. 2013;22:383–8.
- Fogari R, Mugellini A, Destro M, Corradi L, Zoppi A, Fogari E, Rinaldi A. Losartan and prevention of atrial fibrillation recurrence in hypertensive patients. J Cardiovasc Pharmacol. 2006;47:46–50.
- Fang WT, Li HJ, Zhang H, Jiang S. The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2012 Nov;74(5):744–56.
- Manning BD, Toker A. AKT/PKB Signaling: Navigating the Network. Cell. 2017;169: 381–405.
- Qin W, Cao L, Massey IY. Role of PI3K/Akt signaling pathway in cardiac fibrosis. Mol Cell Biochem. 2021;476:4045–59.
- Zhao Z, Li R, Wang X, Li J, Yuan M, Liu E, Liu T, Li G. Attenuation of atrial remodeling by aliskiren via affecting oxidative stress, inflammation and PI3K/Akt signaling pathway. Cardiovasc Drugs Ther. 2021;35:587–98.
- Ji Y, Ning Z. Paeoniflorin Inhibits Atrial Fibrosis and Atrial Fibrillation in Angiotensin II-Infused Mice Through the PI3K-Akt Pathway. Dose Response. 2024;22:15593258241277919.
- Zhang P, Li H, Zhang A, Wäng X, Song Q, Li Z, Wang W, Xu J, Hou Y, Zhang Y. Mechanism of myocardial fibrosis regulation by IGF-1R in atrial fibrillation through the PI3K/Akt/FoxO3a pathway. Biochem Cell Biol. 2023;101:432–42.
- Haller ST, Yan Y, Drummond CA, Xie J, Tian J, Kennedy DJ, Shilova VY, Xie Z, Liu J, Cooper CJ, Malhotra D, Shapiro JI, Fedorova OV, Bagrov AY. Rapamycin Attenuates Atrial Fibrosis in 5/6 Nephrectomized Rats by Inhibiting Mammalian Target of Rapamycin and Profibrotic Signaling. International Journal of Heart Rhythm. 2017;2:81.
- Bass-Stringer S, Bernardo BC, Yildiz GS, Matsumoto A, Kiriazis H, Harmawan CA, Tai CMK, Chooi R, Bottrell L, Ezeani M, Donner DG, D’Elia AA, Ooi JYY, Mellett NA, Luo J, Masterman EI, Janssens K, Olshansky G, Howden EJ, Cross JH, Hagemeyer CE, Lin RCY, Thomas CJ, Magor GW, Perkins AC, Marwick TH, Kawakami H, Meikle PJ, Greening DW, Weeks KL, La Gerche A, Tham YK, McMullen JR. Reduced PI3K(p110α) induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation. J Sport Health Sci. 2025;14:101023.
- Hou A, Shi D, Huang H, Liu Y, Zhang Y. Inflammation pathways as therapeutic targets in angiotensin II induced atrial fibrillation. Front Pharmacol. 2025;16:1515864.
- Ko TH, Jeong D, Yu B, Song JE, Le QA, Woo SH, Choi JI. Inhibition of late sodium current via PI3K/Akt signaling prevents cellular remodeling in tachypacing-induced HL-1 atrial myocytes. Pflugers Arch. 2023;475:217–31.
- Matsumori A. Nuclear Factor-κB is a Prime Candidate for the Diagnosis and Control of Inflammatory Cardiovascular Disease. Eur Cardiol. 2023;18:e40.
- Badreldin H, El-Karef A, Ibrahim T, Elshal M. Targeting Nrf2/HO-1 and NF-κB/TNF-α signaling pathways with empagliflozin protects against atrial fibrillation-induced acute kidney injury in rats. Toxicology. 2024;506:153879.
- Gao G, Dudley SC. Redox Regulation, NF-κB, and Atrial Fibrillation. Antioxid Redox Signal. 2009;11:2265–77.
- Shang LL, Sanyal S, Pfahnl AE, Jiao Z, Allen J, Liu H, Dudley SC Jr. NF-κB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II. Am J Physiol Cell Physiol. 2008;294:C372–9.
- Ajoolabady A, Nattel S, Lip GYH, Ren J. Inflammasome Signaling in Atrial Fibrillation. JACC. 2022;79:2349–66.
- Gramley F, Lorenzen J, Koellensperger E, Kettering K, Weiss C, Munzel T. Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway. Int J Cardiol. 2010;143:405–13.
- He X, Gao X, Peng L, Wang S, Zhu Y, Ma H, Lin J, Duan DD. Atrial Fibrillation Induces Myocardial Fibrosis Through Angiotensin II Type 1 Receptor-Specific Arkadia-Mediated Downregulation of Smad7. Circulation Research. 2011;108:164–75.
- Scridon A, Gallet C, Arisha MM, Oréa V, Chapuis B, Li N, Tabib A, Christé G, Barrès C, Julien C, Chevalier P. Unprovoked atrial tachyarrhythmias in aging spontaneously hypertensive rats: the role of the autonomic nervous system. Am J Physiol Heart Circ Physiol. 2012;303:H386–92.
- Du L, Qin M, Yi Y, Chen X, Jiang W, Zhou L, Zhang D, Xu K, Yang Y, Li C, Liu Y, Liu X, Duan SZ. Eplerenone Prevents Atrial Fibrosis via the TGF-β Signaling Pathway. Cardiology 2017;138:55–62.
- Singh MV, Kapoun A, Higgins L, Kutschke W, Thurman JM, Zhang R, et al. Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart. J Clin Invest. 2009;119:986–96.
- Everett TH, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm. 2007;4:S24–7.
- Martin TP, McCluskey C, Cunningham MR, Beattie J, Paul A, Currie S. CaMKIIδ interacts directly with IKKβ and modulates NF-κB signalling in adult cardiac fibroblasts. Cell Signal. 2018;51:166–75.
- Duan HY, Barajas-Martinez H, Antzelevitch C, Hu D. The potential anti arrhythmic effect of SGLT2 inhibitors. Cardiovasc Diabetol. 2024;23:252.
- Frontera A, Latini AC, Krisai P, Battaglia V, Gottlieb LA, Vlachos K, Gigli L, Guarracini F, Baroni M, Preda A, Varrenti M, Vargiu S, Paolucci M, Menè R, Carbonaro M, Colombo G, Brundel BJJM, Christophersen IE, Giannattasio C, De Groot NMS, Mazzone P. From bench to bedside: The clinical relevance of atrial electrical remodeling in atrial fibrillation therapy. Heart Rhythm. 2026;5:S1547-71.
- Katritsis GD, Katritsis DG. Cardiac Autonomic Denervation for Ablation of Atrial Fibrillation. Arrhythm Electrophysiol Rev. 2014;3:113–5.
- Ramos-Mondragón R, Galindo CA, Avila G. Role of TGF-β on cardiac structural and electrical remodeling. Vasc Health Risk Manag. 2008;4:1289–300.
- Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577–84.
Language: English
Published on: Apr 18, 2026
Published by: Romanian Society of Cardiology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Alkora Ioana Balan, Elena Butoi, Mihaela Vadana, Miruna Larisa Naie, Andreea Cristina Mihaila, Alina Scridon, published by Romanian Society of Cardiology
This work is licensed under the Creative Commons Attribution 4.0 License.